Skip to main content
SpringerLink
Log in

Riociguat (Adempas) recommended in Wales

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. All Wales Medicines Strategy Group. Riociguat (Adempas): Reference No. 1608. Internet Document : 9 Oct 2015. Available from: URL: http://www.awmsg.org/awmsgonline/app/appraisalinfo/1608

  2. All Wales Medicines Strategy Group. riociguat (Adempas): Reference No. 558 Internet Document : 9 Oct 2015. Available from: URL: http://www.awmsg.org/awmsgonline/app/appraisalinfo/558

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Riociguat (Adempas) recommended in Wales. PharmacoEcon Outcomes News 740, 37 (2015). https://doi.org/10.1007/s40274-015-2592-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2592-x

Search

Navigation